DE69222840D1 - Verfahren zur herstellung von untereinheisimpfstoff gegen schweinparvovirus - Google Patents

Verfahren zur herstellung von untereinheisimpfstoff gegen schweinparvovirus

Info

Publication number
DE69222840D1
DE69222840D1 DE69222840T DE69222840T DE69222840D1 DE 69222840 D1 DE69222840 D1 DE 69222840D1 DE 69222840 T DE69222840 T DE 69222840T DE 69222840 T DE69222840 T DE 69222840T DE 69222840 D1 DE69222840 D1 DE 69222840D1
Authority
DE
Germany
Prior art keywords
ppv
vaccine against
capsides
protein
recombinant baculovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69222840T
Other languages
English (en)
Other versions
DE69222840T2 (de
Inventor
Alvarez Jose Casal
Valdes Elena Cortes
Casares Ana Ranz
Olmo Carmen Vela
Kristian Dalsgaard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inmunologia y Genetica Aplicada SA
Original Assignee
Inmunologia y Genetica Aplicada SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inmunologia y Genetica Aplicada SA filed Critical Inmunologia y Genetica Aplicada SA
Application granted granted Critical
Publication of DE69222840D1 publication Critical patent/DE69222840D1/de
Publication of DE69222840T2 publication Critical patent/DE69222840T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/818Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/826Viruses
DE69222840T 1991-03-26 1992-03-26 Verfahren zur herstellung von untereinheisimpfstoff gegen schweinparvovirus Expired - Lifetime DE69222840T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES9100845A ES2026827A6 (es) 1991-03-26 1991-03-26 Procedimiento para la produccion de una vacuna subunidad contra el parvovirus porcino.
PCT/ES1992/000032 WO1992017589A1 (es) 1991-03-26 1992-03-26 Procedimiento para la produccion de una vacuna subunidad contra el parvovirus porcino

Publications (2)

Publication Number Publication Date
DE69222840D1 true DE69222840D1 (de) 1997-11-27
DE69222840T2 DE69222840T2 (de) 1998-05-14

Family

ID=8271931

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69222840T Expired - Lifetime DE69222840T2 (de) 1991-03-26 1992-03-26 Verfahren zur herstellung von untereinheisimpfstoff gegen schweinparvovirus

Country Status (8)

Country Link
US (1) US5498413A (de)
EP (1) EP0551449B1 (de)
AT (1) ATE159547T1 (de)
AU (1) AU1537792A (de)
DE (1) DE69222840T2 (de)
DK (1) DK0551449T3 (de)
ES (1) ES2026827A6 (de)
WO (1) WO1992017589A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993001833A1 (en) * 1991-07-17 1993-02-04 Commonwealth Scientific And Industrial Research Organisation Improved vaccine
DK0647655T3 (da) * 1993-01-23 1999-08-23 Inmunologia & Genetica Aplic Syntetiske peptider og vacciner mod parvovirus
ES2080023B1 (es) * 1994-07-08 1996-08-16 Iberica Cyanamid Capsidas y proteinas recombinantes del virus de la enfermedad hemorragica del conejo (rhdv), kits de diagnostico y vacunas que contienen dichos productos recombinantes.
JP4117027B2 (ja) * 1996-04-19 2008-07-09 コルパン メチン パルボウイルス感染のための核酸予防接種
CA2223029A1 (en) * 1997-02-12 1998-08-12 Akzo Nobel Nv Canine parvovirus dna vaccines
US7192594B2 (en) 1997-10-03 2007-03-20 Merial Limited Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
FR2781159B1 (fr) 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
DE07008633T1 (de) * 1997-12-11 2008-12-18 Merial Virus des multisystemischen Kümmersyndroms bei Absatzferkeln
BR9804283B1 (pt) * 1998-03-18 2010-11-30 processo para a produção de flavivìrus em baixa densidade de células em cultura e processo para a produção de flavivìrus recombinante em baixa densidade de células em cultura.
ES2139537B1 (es) * 1998-03-24 2000-10-01 Inmunologia & Genetica Aplic Sistema de presentacion de antigenos basado en el virus de la sharka.
US6238860B1 (en) 1998-11-05 2001-05-29 Dyax Corp. Binding moieties for human parvovirus B19
SE516522C2 (sv) 1999-05-28 2002-01-22 Anoto Ab Positionsbestämning
ES2170622B1 (es) * 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
EP1228234A2 (de) * 2000-03-14 2002-08-07 Neurologix, Inc. Herstellung von vektoren mit chimären kapselproteinen
WO2001094392A2 (en) * 2000-06-05 2001-12-13 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri Food Canada Recombinant subunit proteins from porcine parvovirus produced in plants
PL1968630T3 (pl) * 2005-12-29 2018-08-31 Boehringer Ingelheim Vetmedica, Inc. Multiwalentne immunogenne kompozycje PCV2
CN101851609B (zh) * 2010-02-02 2012-10-03 哈药集团生物疫苗有限公司 猪细小病毒l株及在制备猪细小病毒病灭活疫苗中的用途
EP4091629A1 (de) 2013-09-25 2022-11-23 Zoetis Services LLC Divergente impfstoffzusammensetzung gegen pcv2b und verfahren zur verwendung
TWI788309B (zh) * 2016-11-03 2023-01-01 德商百靈佳殷格翰維美迪加股份有限公司 抗豬小病毒及豬生殖與呼吸道症候群病毒之疫苗及其製造方法
EP3534945A1 (de) * 2016-11-03 2019-09-11 Boehringer Ingelheim Vetmedica GmbH Impfstoff gegen das schweineparvovirus
KR102117811B1 (ko) * 2018-12-05 2020-06-02 대한민국(농림축산식품부 농림축산검역본부장) 재조합 돼지파보바이러스 항원 단백질 및 이의 용도
AU2020256283A1 (en) 2019-04-04 2021-11-18 Boehringer lngelheim Vetmedica GMBH Porcine circovirus type 3 (PCV3) vaccines, and production and uses thereof
CN110845580A (zh) * 2019-11-05 2020-02-28 中国农业科学院兰州兽医研究所 一种猪细小病毒样颗粒的组装及其免疫原性鉴定方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0117767A1 (de) * 1983-01-07 1984-09-05 Mgi Pharma, Inc. Herstellung von Untereinheiten von Parvovirus-Vakzinen
EP0322417A1 (de) * 1986-09-08 1989-07-05 Applied Biotechnology, Inc. Leere virus kapsidvakzine
US4971793A (en) * 1988-05-09 1990-11-20 Boyce Thompson Institute For Plant Research, Inc. Subunit canine parvovirus vaccine
DD286820A5 (de) * 1989-08-10 1991-02-07 Univ Berlin Humboldt Verfahren zur herstellung des rekombinanten proteins hbcag delta-hivp24, das eine fusion aus den coreproteinen von hepatitis b-virus und humahem immundefizienzvirus 1 darstellt

Also Published As

Publication number Publication date
EP0551449B1 (de) 1997-10-22
ES2026827A6 (es) 1992-05-01
AU1537792A (en) 1992-11-02
US5498413A (en) 1996-03-12
DE69222840T2 (de) 1998-05-14
ATE159547T1 (de) 1997-11-15
DK0551449T3 (da) 1998-07-20
WO1992017589A1 (es) 1992-10-15
EP0551449A1 (de) 1993-07-21

Similar Documents

Publication Publication Date Title
DE69222840T2 (de) Verfahren zur herstellung von untereinheisimpfstoff gegen schweinparvovirus
DE69223939D1 (de) Verfahren zur herstellung von untereinheitsimpfstoff gegen hundeparvovirus und verwandten viren
Dertzbaugh Genetically engineered vaccines: an overview
DK157087D0 (da) Multivalent vaccine, isaer herpesvirusvaccine, dens anvendelse og deri indgaaende virus
KR920703831A (ko) 백신(vaccines)
EP1298139A3 (de) Auf Herpesvirus gegründeter rekombinanter Impfstoff gegen die infektiöse Bursalkrankheit
MXPA01008966A (es) Vacunas contra el virus sincicial respiratorio a base de acido nucleico.
MX2010000235A (es) Virus del sindrome respiratorio y reproductivo porcino tipo 1 norteamericano recombinante y metodos de uso.
WO1998055626A3 (en) Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine
Thomas et al. Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus
JP2009544303A5 (de)
Fahey et al. A recombinant subunit vaccine that protects progeny chickens from infectious bursal disease
Hoshino et al. Serological comparison of canine rotavirus with various simian and human rotaviruses by plaque reduction neutralization and hemagglutination inhibition tests
ATE102650T1 (de) Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung.
KR960705944A (ko) 소 바이러스성 설사 바이러스(bvdv) 항원을 갖는 바이러스 벡터(viral vector with bovine viral diarrhea virus(bvdv)antigens)
EP1512693A3 (de) Polypeptid, dafür kodierende DNA, diese DNA beinhaltender, rekombinanter Vektor, Herstellung eines rekombinanter Virus unter Verwendung dieses Vektors und dessen Anwendung
WO1994000586A3 (fr) Mutants et vaccins du virus de la rhinotracheite infectieuse bovine
McKenna et al. Formation of infectious pancreatic necrosis Virus–like particles following expression of segment a by recombinant semliki forest virus
RU2006106427A (ru) Вакцина
DE69203950D1 (de) Rekombinanter Impfstoff gegen Marek's Krankheit.
ES2105984A1 (es) Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.
ES2074965A1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
CA2402339A1 (en) Viral antigen and vaccine against isav (infectious salmon anaemia virus)
Joklik Antigenic relationships between the proteins of the three serotypes of reovirus.
TH31919B (th) รีคอมบิแนนท์วัคซีนของนกที่มีเฮอร์ปีส์ไวรัสของนกที่มีชีวิตโดยเฉพาะการต้านโรคกัมโบโร

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 551449

Country of ref document: EP